Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Clinical trial NCT00920582 · TERMINATED

Trial details

NCT number: NCT00920582
Sponsor: MacroGenics
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2009-09-01
Primary completion: 2012-04-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.